New PDUFA Action Date Assigned for Labopharm Drug; FDA Could Rule in February

Reuters -- Canadian drugmaker Labopharm Inc said on Tuesday that U.S. regulators have accepted its latest filing regarding the antidepressant trazodone and that a decision on the drug could come in February.